COMPLEX TREATMENT OF LOCALLY ADVANCED MALIGNANT TUMORS OF THE THYROID GLAND WITH INVASION INTO THE ORGANS OF THE NECK AND MEDIASTINUM
Clinical medicine

COMPLEX TREATMENT OF LOCALLY ADVANCED MALIGNANT TUMORS OF THE THYROID GLAND WITH INVASION INTO THE ORGANS OF THE NECK AND MEDIASTINUM

Published 2024-05-15

Authors:

I.V. Deineko

Abstract:
Patients with locally advanced thyroid cancer require particular attention, as the selection of surgical techniques and a logical program of complex therapy for them remain controversial. Given the significant complexity and prevalence of fatal complications in cases of tumor stenosis of the upper airway during emergency tracheostomy, it is recommended that the patient be prepared for radical or palliative surgery in a prepared operating room in a planned manner with patient intubation, if possible. Given the high proportion of locally advanced, highly differentiated tumors that are refractory to radioiodine therapy and have a high malignant potential, as well as the poor prognosis associated with local recurrence of the disease, surgical intervention as part of a comprehensive treatment plan should be as radical and aggressive as possible, with macroscopic removal of the entire tumor, including all invasions of organs and tissues of the neck and mediastinum, especially in cases of medium and low-grade tumors. Conversely, when planning a traumatic surgery, it is essential to consider the patient's general condition, age, and comorbidities. In cases where traumatic surgery is contraindicated, particularly in highly differentiated cancers, less radical methods of "shaving" the tumor without compromising the integrity of the organ may be employed.
Keywords:
malignant thyroid tumors surgical tactics upper respiratory tract
References:
  1. Deineko IV. Optymizatsiya kompleksnoho likuvannya khvorykh iz mistsevo poshyrenymy zloyakisnymy pukhlynamy shchytopodibnoyi zalozy z invaziyeyu abo kompresiyeyu verkhnikh dykhalnykh shlyakhiv. Klinichna endokrynolohiya ta endokrynna khirurhiya.3 (83) 2023, С. 26–34 http://doi.org/10.30978/CEES-2023-3-26 [in Ukrainian]
  2. Deineko IV, Zhmurenko EV, Kravchenko VA, Merenkova SP. Kombinovane ta kompleksne likuvannya khvorykh na vysokodyferentsiyovanyy mistsevo-rozpovsyudzhenyy rak shchytopodibnoyi zalozy. Lvivskyy medychnyy chasopys =Acta medica leopoliensia. 10/019; 25(4):18–22 doi: https://doi.org/10.25040/aml2019.04.018 [in Ukrainian]
  3. Fetisov VS. Paket statystychnoho analizu danykh STATISTICA: navch. posib. Nizhyn: NDU im. M. Hoholya; 2018. 114 s. http://lib.ndu.edu.ua/dspace/handle/123456789/32 [in Ukrainian]
  4. Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27–63. doi: https://doi.org/10.1007/s12022-022-09707-3
  5. Fallahi P, Ferrari SM, Elia G. Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes. Cancer Manag Res. 2019 Aug 21; 11:7893–907. doi: http://doi.org/10.2147/CMAR.S127848.
  6. Fugazzola L. 2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer. Eur Thyroid J 2019; 8: 227–245 doi: https://doi.org/10.1159/000502229
  7. Haugen BR, Alexander EK, Bible KC. 2015 American Thyroid association Management Guidelines for adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133. doi: https://doi.org/10.1089/thy.2015.0020
  8. Houten R, Fleeman N, Kotas E, Boland A, Lambe T, Duarte R. A systematic review of health state utility values for thyroid cancer. Qual Life Res. 2021;30(3):675–702 doi: https://doi.org/10.1007/s11136-020-02676-2
  9. Hyeong SA, Hyun JK, Kyoung HK. Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality. Тhyroid. 2016; 26(11): 1535–1540. doi: https://doi.org/10.1089/thy.2016.0075
  10. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212. doi: https://doi.org/10.1155/2013/965212
  11. Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on Fundamental Mechanisms of Thyroid Cancer. Front Endocrinol (Lausanne). 2020; 11:102 doi: https://doi.org/10.3389/fendo.2020.00102
  12. Roka R. Surgical treatment of locally advanced thyroid cancer. Innov Surg Sci 2020; 5(1–2): 27–34 doi: https://doi.org/10.1515/iss-2020-0012
Publication:
«World of Medicine and Biology» Vol. 20 No. 88 (2024) , с. 53-58
УДК 616.441-006.6-036.4-033.2:611.93:616.27]-08